AbCellera's menopause drug reduces hot flashes in mid-stage trial
AbCellera's menopause drug reduces hot flashes in mid-stage trial Aug 10 (Reuters) - AbCellera ABCL.O said on Monday its experimental menopause treatment significantly reduced the frequency and severity of hot flashes in a mid-stage trial.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Tasim Zahid)
Recent news on AbCellera Biologics
See all newsAbCellera Biologics Inc. reports results for the quarter ended September 30 - Earnings Summary
Canada's AbCellera Q3 revenue beats analyst estimates
Factbox: Pharma sector doubles down on AI to slash costs, timelines
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce